| [1] |
Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [2] |
Coyle C, Cafferty FH, Vale C, et al.Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J]. Ann Oncol, 2016, 27(12): 2184-2195.
|
| [3] |
Jiralerspong S, Palla SL, Giordano SH, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer [J]. J Clin Oncol, 2009, 27(20): 3297-3302.
|
| [4] |
Chen TM, Lin CC, Huang PT, et al. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation [J]. J Gastroenterol Hepatol, 2011, 26(5): 858-865.
|
| [5] |
Garrett CR, Hassabo HM, Bhadkamkar NA, et al. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer [J]. Br J Cancer, 2012, 106(8): 1374-1378.
|
| [6] |
Mc Menamin UC, Murray LJ, Hughes CM, et al. Metformin use and survival after colorectal cancer: A population-based cohort study [J]. Int J Cancer, 2016, 138(2): 369-379.
|
| [7] |
周小智, 薛耀明, 朱波，等. 二甲双胍对人结肠癌细胞株SW-480增殖的影响 [J]. 南方医科大学学报, 2010, 30(8): 1935-1938, 1942.
|
| [8] |
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia [J]. Nat Rev Cancer, 2008, 8(12): 915-928.
|
| [9] |
Adachi Y, Lee CT, Coffee K, et al. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines [J]. Gastroenterology, 2002, 123(4): 1191-1204.
|
| [10] |
Shackelford DB, Abt E, Gerken L, et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin [J]. Cancer Cell, 2013, 23(2): 143-158.
|
| [11] |
Faubert B, Boily G, Izreig S, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo [J]. Cell Metab, 2013, 17(1): 113-124.
|
| [12] |
Morales DR, Morris AD. Metformin in cancer treatment and prevention [J]. Annu Rev Med, 2015, 66: 17-29.
|